As these cell lines are HER2-overexpressed and HER2-underexpressed respectively, and HER2 is among the most sensitive Hsp90 clients [39], we assume that FW-04-806 has a preferential inhibitory effect on HER2-overexpressed cancer cells. Here, ERBB2 is linked to cancer.